We are live on ! Find out more
SPXV icon

ProShares S&P 500 ex-Health Care ETF

23 hedge funds and large institutions have $20.9M invested in ProShares S&P 500 ex-Health Care ETF in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

23% more capital invested

Capital invested by funds: $17M → $20.9M (+$3.86M)

15% more funds holding

Funds holding: 2023 (+3)

2.57% more ownership

Funds ownership: 64.46%67.03% (+2.6%)

Holders
23
Holders Change
+3
Holders Change %
+15%
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

SPXV Hedge Fund Activity: Q2 2025 in Review

23 of the 7,615 institutional investors tracked by Wall St. Rank reported a position in ProShares S&P 500 ex-Health Care ETF (SPXV) for Q2 2025, worth a combined $20.9M — up 23% from $17M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new SPXV positions and 0 closed out — a net gain of 3 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Bank of America, adding an estimated $766K. The largest seller was UBS Group, cutting an estimated $10.6K.

  • 23 institutional investors held ProShares S&P 500 ex-Health Care ETF (SPXV) as of Q2 2025, up from 20 in Q1 2025.
  • Funds reported $20.9M of ProShares S&P 500 ex-Health Care ETF stock for Q2 2025, up 23% quarter-over-quarter.
  • 3 funds opened new ProShares S&P 500 ex-Health Care ETF positions in Q2 2025 and 0 closed out, a net change of +3 holders.
  • The largest ProShares S&P 500 ex-Health Care ETF buyer in Q2 2025 was Bank of America, an estimated $766K added.
  • The largest ProShares S&P 500 ex-Health Care ETF seller in Q2 2025 was UBS Group, an estimated $10.6K sold.

Based on aggregated 13F filings for Q2 2025.